Provided by Tiger Trade Technology Pte. Ltd.

OptimizeRx Corporation

7.96
+0.00500.06%
Volume:41.81K
Turnover:329.56K
Market Cap:149.23M
PE:32.33
High:8.01
Open:7.89
Low:7.71
Close:7.95
52wk High:22.25
52wk Low:4.54
Shares:18.76M
Float Shares:14.50M
Volume Ratio:0.39
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2461
EPS(LYR):0.2700
ROE:3.68%
ROA:4.22%
PB:1.14
PE(LYR):29.46

Loading ...

OptimizeRx shareholders approve 1 million-share increase to 2021 equity plan reserve

Reuters
·
Jun 13

OptimizeRx publishes corporate presentation on AI-driven healthcare marketing platform DAAP

Reuters
·
May 21

OptimizeRx partners with DeepIntent to integrate authenticated EHR network into DSP platform

Reuters
·
May 21

OptimizeRx (OPRX) Q1 Loss Tests Bullish Narrative Around Recently Improved Profitability

Simply Wall St.
·
May 14

OptimizeRx price target lowered to $11 from $20 at Lake Street

TIPRANKS
·
May 13

OptimizeRx Is Maintained at Equal-Weight by Stephens & Co.

Dow Jones
·
May 13

B. Riley Securities Remains a Buy on OptimizeRx (OPRX)

TIPRANKS
·
May 13

B. Riley Adjusts Price Target on OptimizeRx to $10 From $11, Maintains Buy Rating

MT Newswires Live
·
May 13

Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), ProQR (PRQR) and OptimizeRx (OPRX)

TIPRANKS
·
May 13

OptimizeRx reports Q1 EPS 14c, consensus 0c

TIPRANKS
·
May 13

BRIEF-Optimizerx Corp - Enters Credit Agreement With Fifth Third Bank On May 7, 2026 - SEC Filing

Reuters
·
May 13

OptimizeRx Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

OptimizeRx Q1 Adj. EPS $0.14 Beats $0.00 Estimate, Sales $19.844M Beat $18.353M Estimate

Benzinga Earnings
·
May 13

OptimizeRx Q1 revenue beats analyst estimates

Reuters
·
May 13

OptimizeRx Corp - Credit Agreement Includes up to $25 Mln Incremental Accordion Feature - SEC Filing

THOMSON REUTERS
·
May 13

BRIEF-OPTIMIZERx Q1 Revenue USD 19.8 Million Vs. IBES Estimate USD 18.4 Million

Reuters
·
May 13

OptimizeRx Q1 net loss narrows to $(0.5) million; revenue falls 10% to $19.8 million

Reuters
·
May 13

OptimizeRx Outlook FY Revenue USD 95-100 Million

THOMSON REUTERS
·
May 13

OptimizeRx Q1 Adjusted Net Income USD 2.7 Million VS. Ibes Estimate USD -31.2 Thousand

THOMSON REUTERS
·
May 13

OptimizeRx Q1 Adjusted EPS USD 0.14

THOMSON REUTERS
·
May 13